Literature DB >> 20605701

Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls.

Katrine V Wirgenes1, Srdjan Djurovic, Kjetil Sundet, Ingrid Agartz, Morten Mattingsdal, Lavinia Athanasiu, Ingrid Melle, Ole A Andreassen.   

Abstract

BACKGROUND: The gene encoding Catechol O-methyltransferase (COMT), a dopamine catabolic enzyme, is an important candidate gene in several psychiatric disorders. Several studies have shown an association between the functional Val(158)Met polymorphism and cognitive performance. However, the results have been inconsistent and there are few studies addressing other COMT single nucleotide polymorphisms (SNPs).
METHODS: We investigated SNPs across the whole COMT gene, including the Val(158)Met polymorphism, for a putative effect on working memory, executive function and IQ in 315 patients with schizophrenia or bipolar disorder and 340 healthy controls.
RESULTS: We replicated the association between the Val(158)Met variant and working memory performance, and found a significant interaction between this SNP and diagnosis, with patients with schizophrenia showing a specific, reduced performance on the 2-back test. Several other COMT SNPs were associated with different cognitive functions, but did not remain significant after controlling for multiple testing. We also found significant interaction effects between the SNP variants and gender.
CONCLUSIONS: The present study replicates earlier findings showing an association between the functional Val(158)Met polymorphism and working memory performance, with schizophrenia subjects particularly vulnerable. Furthermore, our findings suggest that other parts of the COMT gene seem to affect several related cognitive domains, which further support the notion that COMT is a modifier gene in prefrontal dopamine functioning. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605701     DOI: 10.1016/j.schres.2010.05.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  11 in total

Review 1.  COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation.

Authors:  Elisa Ira; Martina Zanoni; Mirella Ruggeri; Paola Dazzan; Sarah Tosato
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

Review 2.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

3.  COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls.

Authors:  Alan Ceaser; John G Csernansky; Deanna M Barch
Journal:  Cogn Neuropsychiatry       Date:  2012-10-03       Impact factor: 1.871

4.  COMT genotype and response to cognitive remediation in schizophrenia.

Authors:  Jean-Pierre Lindenmayer; Anzalee Khan; Herbert Lachman; Susan R McGurk; Abraham Goldring; Amod Thanju; Saurabh Kaushik
Journal:  Schizophr Res       Date:  2015-08-06       Impact factor: 4.939

5.  COMT Val158Met genotype influences neurodegeneration within dopamine-innervated brain structures.

Authors:  E D Gennatas; J A Cholfin; J Zhou; R K Crawford; D A Sasaki; A Karydas; A L Boxer; S J Bonasera; K P Rankin; M L Gorno-Tempini; H J Rosen; J H Kramer; M Weiner; B L Miller; W W Seeley
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

Review 6.  Biomarkers of bipolar disorder: specific or shared with schizophrenia?

Authors:  Frank Bellivier; Pierre Alexis Geoffroy; Jan Scott; Franck Schurhoff; Marion Leboyer; Bruno Etain
Journal:  Front Biosci (Elite Ed)       Date:  2013-06-01

7.  Catechol-O-methyltransferase Val158Met polymorphism associates with individual differences in sleep physiologic responses to chronic sleep loss.

Authors:  Namni Goel; Siobhan Banks; Ling Lin; Emmanuel Mignot; David F Dinges
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

8.  Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals.

Authors:  Hiroaki Hori; Noriko Yamamoto; Takashi Fujii; Toshiya Teraishi; Daimei Sasayama; Junko Matsuo; Yumiko Kawamoto; Yukiko Kinoshita; Miho Ota; Kotaro Hattori; Masahiko Tatsumi; Kunimasa Arima; Hiroshi Kunugi
Journal:  Sci Rep       Date:  2012-09-06       Impact factor: 4.379

9.  Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158 Met genotype.

Authors:  Baer Arts; Claudia J P Simons; Marjan Drukker; Jim van Os
Journal:  BMC Psychiatry       Date:  2013-02-19       Impact factor: 3.630

10.  Lack of association between COMT and working memory in a population-based cohort of healthy young adults.

Authors:  Margaret C Wardle; Harriet de Wit; Ian Penton-Voak; Glyn Lewis; Marcus R Munafò
Journal:  Neuropsychopharmacology       Date:  2013-01-21       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.